1. Home
  2. TNYA

TNYA

Tenaya Therapeutics Inc.

Logo Tenaya Therapeutics Inc.

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

as 04-22-2024 11:32am EST

$
-
.
-
-
-
$
-
.
-
-
-
.
-
-
%

Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.

Founded: 2016 Country:
United States
United States
Employees: 140 City: SOUTH SAN FRANCISCO
Market Cap: 339.2M IPO Year: 2021
Target Price: $15.40 AVG Volume (30 days): 614.3K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.68 EPS Growth: N/A
52 Week Low/High: $1.66 - $8.09 Next Earning Date: 05-08-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): 436.66%

Share on Social Networks:

Stock Insider Trading Activity of Tenaya Therapeutics Inc. (TNYA)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
COLUMN GROUP III GP, LP TNYA 10% Owner Feb 12 '24 Buy $4.50 2,222,222 $9,999,999.00 13,599,275 SEC Form 4
GOEDDEL DAVID V TNYA Director10% Owner Feb 12 '24 Buy $4.50 2,222,222 $9,999,999.00 13,599,275 SEC Form 4